Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2

27 Oct 2022

Abstract excerpt

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concerns (VOCs) continue to emerge, cross-neutralizing antibody responses become key toward next-generation design of a more universal COVID-19 vaccine. By analyzing published data from the literature, we report here that the combination of germline genes IGHV2-5/IGLV2-14 represents a public antibody response to the receptor-binding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Monoclonal and Polyclonal Antibodies Research
Share to SARS-CoV-2 and COVID-19 Research
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36335937
DOI: 10.1016/j.celrep.2022.111650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2PMID 36335937Read ↗

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2Semantic proximity Read ↗

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodiesSemantic proximity Read ↗

The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2Semantic proximity Read ↗

A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronavirusesSemantic proximity Read ↗

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variantsSemantic proximity Read ↗

Shared N417-dependent epitope on the SARS-CoV-2 Omicron, Beta and Delta-plus variantsSemantic proximity Read ↗

A broadly neutralizing antibody recognizing a unique epitope with signature motif common across coronaviral familiesSemantic proximity Read ↗

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variantsSemantic proximity Read ↗

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecovirusesSemantic proximity Read ↗

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecovirusesSemantic proximity Read ↗

An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape.Semantic proximity Read ↗

A population antibody response against SARS-CoV-2 with differential neutralization activities towards the Delta and Omicron variantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.